Rushnet Inc
RushNet, Inc. provides laboratory diagnostic testing services. It offers high-complexity urine drug testing, behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease services. The company is based in Jacksonville, Florida.
Rushnet Inc (RSHN) - Net Assets
Latest net assets as of March 2024: $-197.24K USD
Based on the latest financial reports, Rushnet Inc (RSHN) has net assets worth $-197.24K USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.29 Million) and total liabilities ($4.49 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-197.24K |
| % of Total Assets | -4.6% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 432.47 |
Rushnet Inc - Net Assets Trend (1998–2023)
This chart illustrates how Rushnet Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Rushnet Inc (1998–2023)
The table below shows the annual net assets of Rushnet Inc from 1998 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-191.39K | -146.09% |
| 2022-12-31 | $415.28K | -58.22% |
| 2021-12-31 | $993.93K | +97.29% |
| 2020-12-31 | $503.80K | +368.05% |
| 2019-12-31 | $-187.95K | -267.81% |
| 2018-12-31 | $112.00K | -88.41% |
| 1999-12-31 | $965.98K | +1030.57% |
| 1998-12-31 | $85.44K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Rushnet Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 196926300.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $58.57K | % |
| Other Comprehensive Income | $6.00K | % |
| Other Components | $430.18K | % |
| Total Equity | $-191.39K | 100.00% |
Rushnet Inc Competitors by Market Cap
The table below lists competitors of Rushnet Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CTGX Mining Inc
PINK:CHCX
|
$1.90 |
|
Auri Inc
PINK:AURI
|
$1.91 |
|
Ecom Products Group Corporation
PINK:EPGC
|
$1.91 |
|
Tamino Minerals Inc
PINK:TINO
|
$1.91 |
|
Clearwave Telecommunications Inc
PINK:CWTC
|
$1.90 |
|
Democrasoft Holdings Inc
PINK:DEMO
|
$1.90 |
|
Blue Diamond Ventures Inc
PINK:BLDV
|
$1.90 |
|
Saguaro Holdings Corp
PINK:SGUJ
|
$1.90 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Rushnet Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 415,283 to -191,389, a change of -606,672 (-146.1%).
- Net loss of 607,028 reduced equity.
- Other factors increased equity by 356.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-607.03K | -317.17% |
| Other Changes | $356.00 | +0.19% |
| Total Change | $- | -146.09% |
Book Value vs Market Value Analysis
This analysis compares Rushnet Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $8.31 | $0.00 | x |
| 2018-12-31 | $0.00 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
| 2023-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Rushnet Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -33.95%
- • Asset Turnover: 0.30x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-332.88%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | -2812.53% | 0.00% | 0.00x | 16.48x | $-2.41 Million |
| 1999 | 71.07% | 29.09% | 2.11x | 1.16x | $589.96K |
| 2018 | 131.10% | 0.00% | 0.00x | 78.42x | $135.64K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-111.10K |
| 2020 | 90.90% | 10.44% | 0.65x | 13.50x | $407.56K |
| 2021 | 16.46% | 2.77% | 0.75x | 7.93x | $64.17K |
| 2022 | -160.05% | -9.63% | 0.94x | 17.61x | $-706.18K |
| 2023 | 0.00% | -33.95% | 0.30x | 0.00x | $-587.89K |
Industry Comparison
This section compares Rushnet Inc's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Rushnet Inc (RSHN) | $-197.24K | -2812.53% | N/A | $1.90 |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |